0,887  0,002  UGT1A9 substrate
0,824  0,003  Monophenol monooxygenase inhibitor
0,816  0,002  Melanin inhibitor
0,804  0,004  Sensitization
0,791  0,004  Lipoxygenase inhibitor
0,784  0,003  Skin whitener
0,772  0,003  UGT1A1 substrate
0,772  0,003  UGT1A3 substrate
0,780  0,014  Transcription factor NF kappa B inhibitor
0,767  0,004  NOS2 expression inhibitor
0,777  0,019  Apoptosis agonist
0,759  0,007  Chemopreventive
0,756  0,004  UGT1A6 substrate
0,756  0,005  CYP2C19 substrate
0,752  0,004  Genotoxic
0,762  0,021  Antiinflammatory
0,744  0,005  Antioxidant
0,732  0,020  Caspase 9 stimulant
0,721  0,009  Antihypercholesterolemic
0,708  0,009  Chemoprotective
0,693  0,013  15-Lipoxygenase inhibitor
0,682  0,005  Free radical scavenger
0,697  0,021  Antineoplastic (breast cancer)
0,676  0,004  Antihypoxic
0,673  0,006  AR expression inhibitor
0,671  0,017  Antidiabetic
0,671  0,017  Cyclophilin D inhibitor
0,640  0,007  Antipyretic
0,635  0,005  UDP-glucuronosyltransferase substrate
0,636  0,009  Antiosteoporotic
0,636  0,020  TNF expression inhibitor
0,623  0,009  Caspase 3 stimulant
0,623  0,010  Cardiovascular analeptic
0,620  0,011  CYP2D6 substrate
0,609  0,003  Estrogen receptor alpha antagonist
0,616  0,011  Proliferative diseases treatment
0,609  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,613  0,013  Bone diseases treatment
0,605  0,017  Carcinogenic
0,594  0,014  Spasmolytic
0,567  0,004  VCAM1 expression inhibitor
0,581  0,019  Respiratory analeptic
0,567  0,012  Nitric oxide antagonist
0,558  0,003  SULT1A3 substrate
0,567  0,012  Antineoplastic (brain cancer)
0,568  0,014  Histamine release inhibitor
0,564  0,010  Hypoglycemic
0,548  0,003  Neurotrophic factor enhancer
0,559  0,015  Cytostatic
0,559  0,021  Antithrombotic
0,545  0,009  Antimutagenic
0,542  0,008  Antihypertriglyceridemic
0,564  0,030  Alzheimer's disease treatment
0,536  0,004  Estrogen receptor beta antagonist
0,529  0,014  Antiamyloidogenic
0,533  0,019  Analeptic
0,512  0,004  UGT2B15 substrate
0,510  0,003  Aromatase inhibitor
0,529  0,027  Prostate cancer treatment
0,521  0,020  Radioprotector
0,502  0,005  Lipid peroxidase inhibitor
0,517  0,020  Cardioprotectant
0,529  0,033  Antibacterial
0,515  0,020  CYP2C19 inhibitor
0,499  0,006  Amylase inhibitor
0,501  0,012  Vascular (periferal) disease treatment
0,491  0,004  Estrogen antagonist
0,496  0,014  Amyloid beta aggregation inhibitor
0,498  0,021  Apoptosis antagonist
0,491  0,014  ICAM1 expression inhibitor
0,509  0,038  Antileukemic
0,506  0,039  CYP3A4 substrate
0,498  0,033  Immunosuppressant
0,482  0,023  Lipoprotein disorders treatment
0,478  0,022  Antineoplastic (glioma)
0,455  0,004  Electron transport complex I inhibitor
0,452  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,473  0,024  NOS3 expression inhibitor
0,492  0,046  Antineoplastic (lung cancer)
0,480  0,034  Teratogen
0,484  0,038  Antipruritic, allergic
0,447  0,004  Antihemorrhagic
0,465  0,028  Hepatic disorders treatment
0,457  0,021  Antidiabetic (type 2)
0,442  0,006  Protein-tyrosine phosphatase inhibitor
0,507  0,079  Alpha-glucosidase inhibitor
0,437  0,008  UGT2B7 substrate
0,458  0,035  Embryotoxic
0,444  0,021  UGT2B4 substrate
0,435  0,014  Antiulcerative
0,425  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,449  0,029  12-Lipoxygenase inhibitor
0,435  0,018  Vasodilator
0,429  0,012  UGT1A4 substrate
0,423  0,007  Sulfotransferase substrate
0,422  0,007  NOS3 expression enhancer
0,419  0,004  Estrogen agonist
0,437  0,023  CYP1A2 inhibitor
0,441  0,032  Cytotoxic
0,438  0,030  CTGF expression inhibitor
0,427  0,026  Antiprotozoal (Leishmania)
0,401  0,003  Estrogen receptor beta agonist
0,410  0,012  5 Hydroxytryptamine uptake stimulant
0,407  0,011  MAO inhibitor
0,429  0,034  CYP1A2 substrate
0,428  0,038  Antifungal
0,395  0,006  Glutathione S-transferase substrate
0,415  0,028  Mutagenic
0,388  0,005  Cholesterol synthesis inhibitor
0,404  0,024  Antiparasitic
0,385  0,005  5-Lipoxygenase inhibitor
0,391  0,013  Antihypotensive
0,398  0,025  Hypolipemic
0,394  0,023  Myocardial infarction treatment
0,398  0,028  Antineoplastic (glioblastoma multiforme)
0,411  0,042  Antineoplastic (ovarian cancer)
0,379  0,019  Antihelmintic
0,376  0,016  GST M1-1 substrate
0,363  0,009  Diabetic nephropathy treatment
0,383  0,030  Superoxide dismutase inhibitor
0,381  0,028  Antidiabetic symptomatic
0,396  0,056  Vasodilator, peripheral
0,397  0,059  CYP2C9 inhibitor
0,340  0,004  Gastritis treatment
0,354  0,018  Hepatoprotectant
0,385  0,056  Antineoplastic (colorectal cancer)
0,332  0,005  Beta glucuronidase inhibitor
0,372  0,047  Antineoplastic (melanoma)
0,328  0,005  AMP-activated protein kinase stimulant
0,334  0,016  Pneumotoxic
0,352  0,035  Antineoplastic (renal cancer)
0,360  0,044  Antineoplastic (cervical cancer)
0,322  0,008  UGT2B9 substrate
0,351  0,037  Antineoplastic (osteosarcoma)
0,370  0,056  Antineoplastic (colon cancer)
0,354  0,041  Antineoplastic (multiple myeloma)
0,336  0,028  Abortion inducer
0,373  0,072  CYP2C9 substrate
0,352  0,051  Antineoplastic (pancreatic cancer)
0,325  0,026  Platelet adhesion inhibitor
0,305  0,012  MAO B inhibitor
0,328  0,042  Transcription factor STAT inhibitor
0,301  0,021  Antineoplastic (squamous cell carcinoma)
0,320  0,044  Transcription factor STAT3 inhibitor
0,290  0,015  Cyclooxygenase 1 inhibitor
0,282  0,009  UGT2B1 substrate
0,289  0,018  Protein kinase stimulant
0,281  0,016  Phospholipase A2 inhibitor
0,283  0,020  Insulin sensitizer
0,287  0,031  P-glycoprotein inhibitor
0,270  0,017  Antidiarrheal
0,264  0,016  LDLR expression enhancer
0,302  0,056  Antineoplastic (non-small cell lung cancer)
0,260  0,014  Cystathionine beta-synthase inhibitor
0,253  0,009  Dementia treatment
0,255  0,011  Farnesoid X receptor antagonist
0,250  0,009  Beta amyloid protein antagonist
0,253  0,012  Xanthine oxidase inhibitor
0,249  0,009  Vascular dementia treatment
0,244  0,004  Lipase inhibitor
0,248  0,009  Androgen antagonist
0,306  0,068  5 Hydroxytryptamine release stimulant
0,240  0,004  Ca(v)3.1 blocker
0,254  0,020  Acetylcholinesterase inhibitor
0,237  0,004  Estrogen receptor alpha agonist
0,285  0,058  Platelet antagonist
0,236  0,009  Arachidonic acid antagonist
0,321  0,099  GST A substrate
0,280  0,060  Antineoplastic (liver cancer)
0,228  0,007  Creatine kinase inhibitor
0,227  0,010  Histidine decarboxylase inhibitor
0,243  0,026  Bone formation stimulant
0,222  0,007  Postmenopausal disorders treatment
0,273  0,059  Antiglaucomic
0,261  0,049  Antineoplastic enhancer
0,317  0,105  Antiobesity
0,218  0,009  Gastric antisecretory
0,275  0,068  Antiprotozoal (Trypanosoma)
0,236  0,030  Skin irritative effect
0,230  0,024  Insulin secretagoues
0,218  0,012  Carbonic anhydrase XIII inhibitor
0,306  0,101  Stroke treatment
0,218  0,015  SULT1A1 substrate
0,206  0,005  Ornithine decarboxylase inhibitor
0,217  0,021  Neurotrophic factor
0,321  0,127  Antiparkinsonian
0,203  0,010  Opioid kappa receptor antagonist
0,196  0,005  Antiviral (SARS coronavirus)
0,196  0,005  Antiviral (Coronavirus)
0,216  0,026  MAO A inhibitor
0,228  0,042  Eye irritation, high
0,209  0,025  DNA polymerase I inhibitor
0,223  0,039  Antiviral (Herpes)
0,212  0,029  UGT2B10 substrate
0,233  0,050  Non-steroidal antiinflammatory agent
0,248  0,067  Antineoplastic (lymphoma)
0,217  0,039  Antineoplastic (carcinoma)
0,188  0,015  HDL-cholesterol increasing
0,234  0,061  RNA-directed DNA polymerase inhibitor
0,217  0,047  Dual specificity phosphatase inhibitor
0,264  0,095  Streptokinase A inhibitor
0,211  0,042  Cholinergic
0,191  0,024  Antibacterial (Helicobacter pylori)
0,187  0,023  Shock treatment
0,175  0,014  Actinic keratosis treatment
0,175  0,014  Urease inhibitor
0,178  0,017  Breast cancer-resistant protein inhibitor
0,289  0,130  Atherosclerosis treatment
0,164  0,004  Fatty acid synthase inhibitor
0,178  0,019  Mucolytic
0,211  0,054  Antipruritic, non-allergic
0,181  0,025  Microtubule formation inhibitor
0,175  0,019  Topoisomerase II alpha inhibitor
0,250  0,096  Immunostimulant
0,159  0,005  SULT1A2 substrate
0,196  0,043  Interleukin 6 antagonist
0,156  0,005  Neuraminidase inhibitor
0,174  0,026  Antineoplastic antibiotic
0,150  0,003  Retinoid X alpha receptor agonist
0,167  0,021  Antineoplastic (uterine cancer)
0,191  0,046  Cyclooxygenase inhibitor
0,154  0,012  Peroxisome proliferator-activated receptor gamma agonist
0,158  0,017  DOPA decarboxylase inhibitor
0,257  0,118  Angiogenesis inhibitor
0,274  0,134  GABA C receptor rho-3 antagonist
0,213  0,073  Psychostimulant
0,159  0,025  Carbonic anhydrase III inhibitor
0,226  0,092  Antineoplastic (sarcoma)
0,147  0,014  Antiviral (Rhinovirus)
0,163  0,030  Expectorant
0,137  0,005  Ca(v)3.2 blocker
0,189  0,058  Succinate dehydrogenase inhibitor
0,159  0,032  Chelator
0,200  0,075  Antiviral (Influenza)
0,250  0,125  Cholesterol antagonist
0,167  0,042  Topoisomerase II inhibitor
0,128  0,004  Sodium/calcium exchanger inhibitor
0,132  0,009  Antiviral (Hepatitis A)
0,149  0,026  Opioid antagonist
0,133  0,013  Leukotriene synthesis inhibitor
0,163  0,043  Antifungal (Cryptococcus)
0,148  0,032  TRPA1 agonist
0,152  0,040  Growth stimulant
0,171  0,059  Antiviral (Influenza A)
0,127  0,015  Bile acid receptor antagonist
0,135  0,023  NAD(P)H dehydrogenase (quinone) inhibitor
0,176  0,064  Antihelmintic (Nematodes)
0,160  0,049  Psychosexual dysfunction treatment
0,125  0,014  Leukotriene antagonist
0,134  0,024  UGT2B11 substrate
0,162  0,053  Alkaline phosphatase inhibitor
0,121  0,012  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,190  0,081  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,112  0,004  Retinoid X receptor agonist
0,131  0,023  SULT1E1 substrate
0,208  0,100  Aldehyde oxidase inhibitor
0,152  0,047  Cyclooxygenase 3 inhibitor
0,121  0,016  Na+ K+ transporting ATPase inhibitor
0,195  0,091  Antialcoholic
0,174  0,069  Toxic, respiratory center
0,214  0,112  Tyrosine 3 hydroxylase inhibitor
0,114  0,013  Neuraminidase (influenza) inhibitor
0,163  0,062  Heat shock protein 90 antagonist
0,158  0,057  Antiacne
0,141  0,043  Carcinogenic, group 2B
0,161  0,063  Antidote
0,108  0,011  Antitreponemal
0,106  0,009  Leukotriene B4 antagonist
0,109  0,013  Xanthine dehydrogenase inhibitor
0,136  0,040  Butyrylcholinesterase inhibitor
0,101  0,006  Postcoital contraceptive
0,133  0,038  Carbonic anhydrase XV inhibitor
0,146  0,052  Ca2+-transporting ATPase inhibitor
0,180  0,086  CYP2B6 inhibitor
0,120  0,026  Opioid delta receptor antagonist
0,102  0,009  Opioid kappa receptor agonist
0,229  0,137  CYP3A4 inhibitor
0,193  0,104  Antineoplastic (lymphocytic leukemia)
0,096  0,008  Transcription factor RelA inhibitor
0,139  0,050  Coagulant
0,126  0,038  Toll-Like receptor 4 antagonist
0,218  0,131  CYP2D6 inhibitor
0,149  0,062  MAP3K9 inhibitor
0,138  0,052  Antitussive
0,156  0,071  Interferon gamma antagonist
0,105  0,021  Narcotic antagonist
0,231  0,149  Sodium/bile acid cotransporter inhibitor
0,141  0,061  Cyclooxygenase 2 inhibitor
0,118  0,038  Antineoplastic alkaloid
0,183  0,104  Angiogenesis stimulant
0,216  0,137  Antimycobacterial
0,145  0,066  Histone deacetylase SIRT1 inhibitor
0,107  0,029  Opioid mu receptor antagonist
0,113  0,036  ABCA1 expression enhancer
0,146  0,069  Adenylate cyclase stimulant
0,140  0,063  Tubulin antagonist
0,093  0,020  Peroxisome proliferator-activated receptor gamma antagonist
0,118  0,046  Bronchodilator
0,126  0,056  Alcohol dehydrogenase substrate
0,105  0,035  Phosphodiesterase 4D inhibitor
0,114  0,046  Anabolic
0,127  0,060  Proteasome inhibitor
0,161  0,094  Antineoplastic (bone cancer)
0,165  0,100  Antiarrhythmic
0,076  0,013  Glucose-6-phosphate translocase inhibitor
0,083  0,021  Exportin-1 inhibitor
0,172  0,111  VEGF expression inhibitor
0,082  0,020  Transcription factor AP-1 inhibitor
0,138  0,077  Hair growth stimulant
0,095  0,034  Keratolytic
0,103  0,043  Alpha 2d adrenoreceptor antagonist
0,222  0,162  Vasodilator, coronary
0,222  0,163  FMO1 substrate
0,108  0,048  Prolactin inhibitor
0,161  0,103  Anesthetic general
0,086  0,029  Secretase beta inhibitor
0,236  0,178  Antiprotozoal
0,072  0,015  Acetyl-CoA transferase 2 inhibitor
0,140  0,084  Peroxidase inhibitor
0,111  0,057  Mediator release inhibitor
0,061  0,007  Peroxisome proliferator-activated receptor alpha antagonist
0,091  0,037  Analgesic, opioid
0,165  0,111  Platelet aggregation inhibitor
0,120  0,066  Autism spectrum disorders treatment
0,064  0,011  Squalene synthetase inhibitor
0,153  0,100  Death-associated protein kinase 2 inhibitor
0,088  0,036  CDC25A inhibitor
0,089  0,040  Antibiotic
0,122  0,072  Antiseptic
0,147  0,099  Dual specificity phosphatase 3 inhibitor
0,114  0,066  Photosensitizer
0,066  0,019  Leukotriene C antagonist
0,070  0,023  Opioid agonist
0,053  0,006  Cholesterol ester transfer protein antagonist
0,118  0,072  Carcinogenic, group 3
0,118  0,071  Antiviral (Influenza B)
0,063  0,018  Squalene epoxidase inhibitor
0,118  0,074  Contraceptive female
0,178  0,134  Nitric-oxide synthase stimulant
0,049  0,007  Leukotriene B4 receptor 1 antagonist
0,075  0,034  SULT2A1 substrate
0,048  0,007  Sodium/glucose cotransporter 2 inhibitor
0,177  0,137  DNA damaging
0,060  0,020  Estradiol 17 beta-dehydrogenase inhibitor
0,065  0,025  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,134  0,096  Thrombolytic
0,051  0,014  Retinoic acid alpha receptor agonist
0,075  0,038  Glucagon-like peptide 1 agonist
0,087  0,049  Adrenaline agonist
0,121  0,084  Cocaine dependence treatment
0,126  0,090  Acaricide
0,062  0,025  Peroxisome proliferator-activated receptor alpha agonist
0,073  0,037  HIV-1 integrase (3'-Processing) inhibitor
0,064  0,030  Aldose reductase inhibitor
0,093  0,061  Uric acid excretion stimulant
0,053  0,021  Cathepsin L2 inhibitor
0,213  0,183  Ulceration
0,061  0,030  Alpha tubulin antagonist
0,137  0,107  Prostate disorders treatment
0,144  0,114  Wound healing agent
0,037  0,008  Sodium/glucose cotransporter inhibitor
0,135  0,107  Uterine stimulant
0,116  0,088  NADPH oxidase inhibitor
0,101  0,072  Choleretic
0,099  0,071  Topoisomerase I inhibitor
0,053  0,027  Opioid mu receptor agonist
0,097  0,072  Gout treatment
0,072  0,047  Prostaglandin-E synthase inhibitor
0,038  0,013  Estrogen-related receptor beta antagonist
0,085  0,061  Dyspepsia treatment
0,045  0,021  Dopamine D5 agonist
0,043  0,019  Leukotriene C4 antagonist
0,121  0,098  Cell wall synthesis inhibitor
0,066  0,043  Dopamine D1 antagonist
0,032  0,009  Sodium/glucose cotransporter 1 inhibitor
0,075  0,053  CYP2A6 inhibitor
0,038  0,017  Tubulin agonist
0,031  0,011  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,098  0,079  GST T1-1 substrate
0,162  0,143  Tumour necrosis factor alpha release inhibitor
0,068  0,051  HIV-1 integrase inhibitor
0,027  0,010  Leukotriene B4 receptor 2 antagonist
0,077  0,062  Glycine receptor antagonist
0,056  0,042  Pregnane X receptor antagonist
0,123  0,108  Antidiabetic (type 1)
0,089  0,077  Alpha 2c adrenoreceptor antagonist
0,021  0,009  Free fatty acid receptor 1 agonist
0,185  0,174  Metabolic disease treatment
0,129  0,118  MAP kinase kinase 4 inhibitor
0,112  0,101  Antifungal enhancer
0,037  0,026  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,105  0,094  Constipation treatment
0,136  0,127  Cardiodepressant
0,064  0,054  Carbonic anhydrase VA inhibitor
0,068  0,060  Alpha 2a adrenoreceptor antagonist
0,145  0,137  Antirickettsial
0,056  0,047  Sphingosine kinase inhibitor
0,110  0,102  Interleukin 4 antagonist
0,037  0,029  Retinoid X receptor antagonist
0,040  0,032  Cholesterol absorption inhibitor
0,020  0,014  Inosine monophosphate dehydrogenase 1 inhibitor
0,073  0,067  Carbonic anhydrase VI inhibitor
0,116  0,110  Diuretic
0,032  0,027  Peroxisome proliferator-activated receptor delta antagonist
0,032  0,028  HMG CoA reductase inhibitor
0,029  0,025  Glucocorticoid antagonist
0,033  0,029  Opioid delta receptor agonist
0,051  0,047  Dihydroorotate oxidase inhibitor
0,039  0,035  Dopamine D2 agonist
0,076  0,072  Alpha 2 adrenoreceptor antagonist
0,117  0,114  Antiprotozoal (Coccidial)
0,104  0,101  Antihyperlipoproteinemic
0,041  0,039  Carbonic anhydrase VII inhibitor
0,105  0,102  Renal failure treatment
0,053  0,052  Androgen agonist
0,048  0,047  Vanilloid 2 antagonist
0,168  0,167  Antineurogenic pain
0,041  0,040  Microtubule stabilization
0,175  0,175  Antiviral (West Nile virus)
0,050  0,050  HIV-1 integrase (Strand Transfer) inhibitor

